Prosecution Insights
Last updated: November 20, 2026
Application No. 19/016,458

METHOD AND APPARATUS FOR PASSING SUTURE THROUGH TISSUE

Non-Final OA §102§103
Filed
Jan 10, 2025
Priority
Sep 10, 2010 — provisional 61/381,787 +13 more
Examiner
MCEVOY, THOMAS M
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Stryker Corporation
OA Round
1 (Non-Final)
71%
Grant Probability
Favorable
1-2
OA Rounds
1y 9m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 71% — above average
71%
Career Allowance Rate
726 granted / 1026 resolved
+0.8% vs TC avg
Strong +36% interview lift
Without
With
+35.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
31 currently pending
Career history
1078
Total Applications
across all art units

Statute-Specific Performance

§101
0.9%
-39.1% vs TC avg
§103
53.3%
+13.3% vs TC avg
§102
24.8%
-15.2% vs TC avg
§112
18.5%
-21.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1026 resolved cases

Office Action

§102 §103
Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. Election/Restrictions Applicant’s election without traverse of Invention I in the reply filed on August 24th 2026 is acknowledged. Claims 14 and 27 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Priority Applicant’s claim for the benefit of a prior-filed application under 35 U.S.C. 119(e) or under 35 U.S.C. 120, 121, 365(c), or 386(c) is acknowledged. Applicant has not complied with one or more conditions for receiving the benefit of an earlier filing date under 35 U.S.C. 120 as follows: The later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or original nonprovisional application or provisional application). The disclosure of the invention in the parent application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) or the first paragraph of pre-AIA 35 U.S.C. 112, except for the best mode requirement. See Transco Products, Inc. v. Performance Contracting, Inc., 38 F.3d 551, 32 USPQ2d 1077 (Fed. Cir. 1994). The disclosure of the prior-filed applications, Applications 13/791395, 13/230652, 61/701920, PCT/US2013/060167, 61/495441, 61/473219, 61/384423 or 61/381787 fail to provide adequate support or enablement in the manner provided by 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph for one or more claims of this application. The above priority applications fail to disclose the limitations of claim 2 lines 11-13 in combination with the step of retracting a suture into the hollow tube so that a loop is formed as recited in claim 2, lines 8-10. The above priority applications also fail to disclose the limitations of claim 15, lines 11-15. Accordingly, November 3ʳᵈ 2014 (the filing date of Application 14/531531) is the earliest date to which the pending claims are being given priority. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of pre-AIA 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (b) the invention was patented or described in a printed publication in this or a foreign country or in public use or on sale in this country, more than one year prior to the date of application for patent in the United States. Claims 2, 3, 6-8 and 10-13 are rejected under pre-AIA 35 U.S.C. 102(b) as being anticipated by Auerbach et al. (US 2013/0218175). Regarding claim 2, Auerbach et al. disclose a method for retaining a suture comprising: extending a distal end of a suture manipulator (144/104; Figure 4) of a suture passer (100; Figure 1) from a hollow tube (102) of the suture passer (¶[0084],[0085]; Figures 9D-9E), the hollow tube comprising a distal end, a proximal end, and a lumen (forming opening 108; ¶[0068]; Figure 2) extending to the distal end, the suture manipulator comprising a distal portion having a catching surface (proximal side of 138; Figures 3 and 11) for catching a portion of a suture; locating a portion of a suture adjacent to the catching surface of the distal portion of the suture manipulator; and retracting the distal portion of the suture manipulator into a distal portion of the hollow tube (¶[0084], [0085]) and pulling the portion of the suture into the hollow tube so that a loop of the suture is located in the lumen (Figure 11; see looped portion of suture within the lumen), wherein a width of a gap between an inner surface of the distal portion of the hollow tube and a side surface of the distal portion of the suture manipulator is less than a width of the distal portion of the suture manipulator (¶[0071]). Regarding claim 3, the method further comprises passing the suture passer with the portion of the suture through tissue (¶[0085], [0086]). Regarding claim 6, the distal portion of the hollow tube is curved (it is curved about the longitudinal axis of the hollow tube). Regarding claim 7, the distal end of the hollow tube tapers to a pointed tip (at “112” - Figure 11). Regarding claim 8, the distal portion of the hollow tube has a longitudinal axis and at least a portion of the suture manipulator extends laterally away from the longitudinal axis (Figure 10). Regarding claim 10, the distal portion of the suture manipulator is bifurcated into a first arm (116) and a second arm (114; Figure 3). Regarding claim 11, the first arm comprises the catching surface (Figure 3). Regarding claim 12, the first arm extends distally of the second arm (Figure 7). Regarding claim 13, the distal end of the suture manipulator comprises a distally facing surface (at “138” - Figure 6), and wherein the catching surface extends parallel relative to the distally facing surface (evident from Figures 6 and 7). Claim Rejections - 35 USC § 103 The following is a quotation of pre-AIA 35 U.S.C. 103(a) which forms the basis for all obviousness rejections set forth in this Office action: (a) A patent may not be obtained though the invention is not identically disclosed or described as set forth in section 102, if the differences between the subject matter sought to be patented and the prior art are such that the subject matter as a whole would have been obvious at the time the invention was made to a person having ordinary skill in the art to which said subject matter pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under pre-AIA 35 U.S.C. 103(a) are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or non-obviousness. Claim 9 is rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Auerbach et al. (US 2013/0218175). Regarding claim 9, Auerbach et al. fail to disclose that the suture is a #2 suture. However, Auerbach et al. disclose that the gap which securely holds the suture should be about 0.5mm (the diameter of some #2 sutures; ¶[0071]). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have used a #2 suture with the suture passer as claimed as an appropriately sized suture that would be securely held within the gap of Auerbach et al. Any #2 suture could be used in at least some orthopedic procedures and can therefore be considered as an orthopedic suture as claimed. Claims 15, 16 and 19-26 are rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Auerbach et al. (US 2013/0218175) in view of Riza (US 5,817,111). Regarding claim 15, Auerbach et al. disclose a method for retaining a suture comprising: extending a distal end of a suture manipulator (144/104; Figure 4) of a suture passer (100; Figure 1) from a hollow tube (102) of the suture passer (¶[0084],[0085]; Figures 9D-9E), the hollow tube comprising a distal end and a lumen (forming opening 108; ¶[0068]; Figure 2) extending to the distal end, the suture manipulator comprising a distal portion having a catching surface (proximal side of 138; Figures 3 and 11) for catching a portion of a suture; locating a portion of a suture adjacent to the catching surface of the distal portion of the suture manipulator; and repositioning the suture manipulator and the hollow tube relative to one another such that the distal portion of the suture manipulator is located within a distal portion of the hollow tube (¶[0084], [0085]), thereby locating a loop of the suture in the lumen (Figure 11; see looped portion of suture within the lumen), wherein a width of a gap between an inner surface of the distal portion of the hollow tube and a side surface of the distal portion of the suture manipulator is less than a width of the distal portion of the suture manipulator (¶[0071]). Auerbach et al. fail to disclose that the portion of the suture is compressed in the gap between the inner surface of the hollow tube and the side surface of the distal portion of the suture manipulator when the portion of the suture is pulled into the lumen. Auerbach et al. intend for a suture to be securely held in the gap between the inner surface of the hollow tube and the side surface of the distal portion of the suture manipulator (¶[0071]). Riza teaches that a suture should be compressed in a similar gap between the inner surface of a hollow tube and the side surface of the distal portion of a suture manipulator in order to more securely hold the suture (col. 7, lines 51-62). It would have been obvious to one of ordinary skill in the art at the time of Applicant’s invention and in view of Riza to have sized the hollow tube, suture manipulator and suture of Auerbach et al. so that the portion of the suture is compressed as claimed in order to more securely hold the suture when passing it through tissue. Regarding claim 16, the method further comprises passing the suture passer with the portion of the suture through tissue (¶[0085], [0086]). Regarding claim 19, the distal portion of the hollow tube is curved (it is curved about the longitudinal axis of the hollow tube). Regarding claim 20, the distal end of the hollow tube tapers to a pointed tip (at “112” - Figure 11). Regarding claim 21, the distal portion of the hollow tube has a longitudinal axis and at least a portion of the suture manipulator extends laterally away from the longitudinal axis (Figure 10). Regarding claim 22, Auerbach et al. fail to disclose that the suture is a #2 suture. However, Auerbach et al. disclose that the gap which securely holds the suture should be about 0.5mm (the diameter of some #2 sutures; ¶[0071]). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have used a #2 suture with the suture passer as claimed as an appropriately sized suture that would be securely held within the gap of Auerbach et al. Any #2 suture could be used in at least some orthopedic procedures and can therefore be considered as an orthopedic suture as claimed. Regarding claim 23, Auerbach et al. disclose that the distal portion of the suture manipulator is bifurcated into a first arm (116) and a second arm (114; Figure 3). Regarding claim 24, the first arm comprises the catching surface (Figure 3 of Auerbach et al.). Regarding claim 25, the first arm extends distally of the second arm (Figure 7 of Auerbach et al.). Regarding claim 26, Auerbach et al. disclose that the distal end of the suture manipulator comprises a distally facing surface (at “138’ - Figure 6), and wherein the catching surface extends parallel relative to the distally facing surface (evident from Figures 6 and 7). Claims 4 and 5 are rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Auerbach et al. (US 2013/0218175) in view of Norton et al. (US 2015/0094739). Regarding claims 4 and 5, Auerbach et al. disclose that the tissue is a labrum or a joint capsule or located in a hip. Auerbach et al. disclose that their invention prevents coring and/or infection when repairing a puncture wound (¶[0049]) Norton et al. teach that a similar suture passer can be used to repair a puncture wound in the labrum of a hip capsule (¶[0038] - “acetabulum”). It would have been obvious to one of ordinary skill in the art at the time of Applicant’s invention and in view of Norton et al. to have used the suture passer of Auerbach et al. to pass a suture through the labrum of the hip to repair a puncture wound therein in order to prevent coring and/or infection. Claims 17 and 18 are rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Auerbach et al. (US 2013/0218175) in view of Riza (US 5,817,111), as applied to claim 16 above, and further in view of Norton et al. (US 2015/0094739). Regarding claims 17 and 18, Auerbach et al. disclose that the tissue is a labrum or a joint capsule or located in a hip. Auerbach et al. disclose that their invention prevents coring and/or infection when repairing a puncture wound (¶[0049]) Norton et al. teach that a similar suture passer can be used to repair a puncture wound in the labrum of a hip capsule (¶[0038] - “acetabulum”). It would have been obvious to one of ordinary skill in the art at the time of Applicant’s invention and in view of Norton et al. to have used the suture passer of Auerbach et al. to pass a suture through the labrum of the hip to repair a puncture wound therein in order to prevent coring and/or infection. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Thomas McEvoy whose telephone number is (571) 270-5034 and direct fax number is (571) 270-6034. The examiner can normally be reached on Monday-Friday, 9:00 am – 6:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, please contact the examiner’s supervisor, Elizabeth Houston at (571) 272-7134. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /THOMAS MCEVOY/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Jan 10, 2025
Application Filed
Nov 04, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12797135
LOCALIZATION SYSTEMS AND METHODS OF USE
3y 5m to grant Granted Nov 17, 2026
Patent 12778735
MEDICAL DEVICES AND ANCHORS THEREFOR
5y 0m to grant Granted Nov 03, 2026
Patent 12778594
Adjustable Arm Device For Grasping Tissues
2y 7m to grant Granted Nov 03, 2026
Patent 12778707
MEDICAL QUICK COUPLING SYSTEM FOR ATTACHING A GUIDE SLEEVE WITHOUT TOOLS
2y 2m to grant Granted Nov 03, 2026
Patent 12765913
PUNCTURE DEVICES AND PUNCTURE SYSTEMS
2y 11m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
71%
Grant Probability
99%
With Interview (+35.5%)
3y 7m (~1y 9m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1026 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month